HSE and Sechenov University Collaborate to Support the Pharmaceutical Industry in Advancing Innovations
Scientists from HSE and Sechenov University have developed a methodology for identifying priority areas and breakthrough technologies to drive the pharmaceutical industry's development. Their joint research, supported by Innopraktika, aims to pinpoint key scientific directions crucial for addressing diseases with significant medical and social impact in the future. An analysis of current and projected data revealed that lung cancer, breast cancer, and stomach cancer contribute the most to the medical, social, and economic burden on healthcare systems.